In collaboration with the Nanomedicine Center for Protein Folding, we have been using our methods to further push a chaperonin inhibitor. This next round will use new scoring functions from…
Read moreWe’ve been using our new Protomol (Core B4) core to study the activation of src Kinase, an enzyme that is involved in the onset of some kinds of cancer.
Read moreDel has been involved in the development of new software methods (Ocker) for the chaperonin inhibitor project.
Read moreDel has presented his plans to the NIH Nanomedicine center with a very positive response. Planning for the lab side of this work has begun.
Read morePlans have started to take a new approach for using FAH to fight cancer: to develop novel chaperonin inhibitors. FAH researcher Del Lucent is taking the lead. See this blog…
Read moreFAH researcher Dr. Lillian Chong presented her work on p53 at a lecture at several US Universities.
Read moreTwo new sets of projects have completed and two new papers are being readied for peer-reviewed publication.
Read moreWe are getting some interesting results from recent new FAH p53 projects.
Read moreWe are expanding FAH’s p53 work to other related p53 systems
Read moreOur first work on cancer has recently been published.
Read more